Global Vitamin D Testing Market 2017-2021
About Vitamin D Testing
Vitamin D is a fat-soluble vitamin that helps in calcium absorption and maintains serum calcium and phosphate concentration to regularize the mineralization of the bone and to prevent hypocalcemic tetany. It plays many roles in the human body such as maintains cell cycle, reduces the chances of neuromuscular disorder and inflammation in joints, and enhances immune function.
Technavio’s analysts forecast the global vitamin D testing market to grow at a CAGR of 4.61% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global vitamin D testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales, volume and value of vitamin D testing specific assay kits.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Vitamin D Testing Market 2017-2021
Technavio recognizes the following companies as the key players in the global vitamin D testing market: F. Hoffmann-La Roche, Abbott, and Siemens Healthineers.
Other Prominent Vendors in the market are: Diazyme Laboratories, Biokit, The Vitamin D Company, Tosoh Bioscience, and QUALIGEN.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is rising number of home-based healthcare services. Home-based healthcare services have become a trend that increases the demand for vitamin D testing for better compatibility, portability, and user-friendly testing method. The vitamin D blood spot testing kit contain the assay and reagent. Also, it costs much lower than hospitals and diagnostic clinics.”
According to the report, one of the major drivers for this market is increase in number of vitamin d deficiency disorders. Vitamin D is associated with major health disorders such as diabetes, kidney disorder, cancer, nutritional rickets, obesity, heart disease, and orthopedic issue. Worldwide, there is an increase in the number of obesity and diabetes cases. According to OECD, in 2014, 18% of the total adult population and children were obese, especially in countries such as Mexico, New Zealand, the US, Canada, Chile, Australia, and England.
Further, the report states that one of the major factors hindering the growth of this market is increasing cost burden on patients. Many clinical diagnostic laboratories and hospital labs provide low-cost assays in a package that combines many tests. The average cost of vitamin D tests is $20 or less, which is not profitable for most large and medium-sized diagnostic laboratories and hospital labs. Therefore, they combined related tests into healthcare package like master health check-up, which costs patients around $180 to $200. This increases the cost burden on the patients and can affect the market negatively.
F. Hoffmann-La Roche, Abbott, Siemens Healthineers, Diazyme Laboratories, Biokit, The Vitamin D Company, Tosoh Bioscience, and QUALIGEN.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook